Hypertension as an Adverse Event Potentially Impacting the Therapeutic Efficacy of Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma
Patients with hypertension occurring as an AE within 9 weeks are expected to have better PFS and OS with atezolizumab plus bevacizumab therapy for uHCC.
Authors
- Takatoshi Nawa (ORCID: https://orcid.org/0000-0002-5604-5676)
- Kazuki Maesaka
- Ryotaro Sakamori (ORCID: https://orcid.org/0000-0002-1580-607X)
- Takeo Usui (ORCID: https://orcid.org/0000-0003-2377-7499)
- Takahiro Kodama (ORCID: https://orcid.org/0000-0002-6250-1324)
- Yuichi Yoshida (ORCID: https://orcid.org/0000-0001-8855-4099)
- Kengo Matsumoto (ORCID: https://orcid.org/0000-0002-1074-026X)
- Yoshinobu Saito (ORCID: https://orcid.org/0000-0002-0624-0449)
- Sadaharu Iio
- Takayuki Yakushijin
- Tetsuo Takehara (ORCID: https://orcid.org/0000-0001-5036-3457)
- Mitsuru Sakakibara (ORCID: https://orcid.org/0000-0003-4649-2082)
- Kazuhiro Murai (ORCID: https://orcid.org/0000-0001-8634-2922)
- Yuki Tahata (ORCID: https://orcid.org/0000-0002-9116-7054)
- Hisashi Ishida (ORCID: https://orcid.org/0000-0002-3391-8403)
- Atsushi Hosui (ORCID: https://orcid.org/0000-0003-0777-8045)
- Kazuyoshi Ohkawa (ORCID: https://orcid.org/0000-0001-9700-2472)
- Naruyasu Kakita (ORCID: https://orcid.org/0000-0002-2991-6456)
- Yoshinori Doi (ORCID: https://orcid.org/0000-0002-2851-7568)
- Hayato Hikita (ORCID: https://orcid.org/0000-0003-2488-7315)
- Machiko Kai
- Masanori Miyazaki (ORCID: https://orcid.org/0000-0002-4989-8929)
- Tomohide Tatsumi
- Akira Doi
- Yasutoshi Nozaki
- Masanori Nakahara
- Kazuho Imanaka
- Kumiko Shirai
- Ryoko Yamada
- N Tatsumi
Institutions
- Ashiya University (JP)
- Osaka University of Economics (JP)
- Osaka Prefectural Medical Center (JP)
- Osaka City University (JP)
- Toyonaka Municipal Hospital (JP)
- Osaka National Hospital (JP)
- Osaka City General Hospital (JP)
- Osaka International Cancer Institute (JP)
- Ikeda Municipal Hospital (JP)
- Higashiosaka College & Higashiosaka Junior College (JP)
- Osaka Rosai Hospital (JP)
- Kansai Rosai Hospital (JP)
- Higashi Osaka City General Hospital (JP)
- Yao Tokushukai General Hospital (JP)
- Suita Municipal Hospital (JP)
- Osaka Hospital (JP)
- Itami City Hospital (JP)
- Japan Community Healthcare Organization (JP)
- Takarazuka City Hospital (JP)
- Hyogo Prefectural Nishinomiya Hospital (JP)
- Osaka University Hospital (JP)
- Otemae Hospital (JP)
- Minoh City Hospital (JP)
- Osaka International University (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Journal of Gastroenterology and Hepatology
- Published
- 2025-09-09
- DOI
- https://doi.org/10.1111/jgh.70068
- Citations
- 2
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 2.64